These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32618974)

  • 1. Intermolecular interactions of cn-716 and acyl-KR-aldehyde dipeptide inhibitors against Zika virus.
    Campos DMO; Bezerra KS; Esmaile SC; Fulco UL; Albuquerque EL; Oliveira JIN
    Phys Chem Chem Phys; 2020 Jul; 22(27):15683-15695. PubMed ID: 32618974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor.
    Lei J; Hansen G; Nitsche C; Klein CD; Zhang L; Hilgenfeld R
    Science; 2016 Jul; 353(6298):503-5. PubMed ID: 27386922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Dynamics of Zika Virus NS2B-NS3 Protease Binding to Dipeptide Inhibitors.
    Li Y; Zhang Z; Phoo WW; Loh YR; Wang W; Liu S; Chen MW; Hung AW; Keller TH; Luo D; Kang C
    Structure; 2017 Aug; 25(8):1242-1250.e3. PubMed ID: 28689970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures and dynamics of peptide and peptidomimetic inhibitors bound to the NS2B-NS3 protease of the ZIKA virus.
    Pant S; Bhattacharya G; Jena NR
    J Biomol Struct Dyn; 2023 Apr; 41(7):3076-3088. PubMed ID: 35238272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease.
    Colarusso S; Ferrigno F; Ponzi S; Pavone F; Conte I; Abate L; Beghetto E; Missineo A; Amaudrut J; Bresciani A; Paonessa G; Tomei L; Montalbetti C; Bianchi E; Toniatti C; Ontoria JM
    Bioorg Med Chem; 2022 Mar; 57():116631. PubMed ID: 35123179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition.
    Coronado MA; Eberle RJ; Bleffert N; Feuerstein S; Olivier DS; de Moraes FR; Willbold D; Arni RK
    Antiviral Res; 2018 Dec; 160():118-125. PubMed ID: 30393012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reaction mechanism of Zika virus NS2B/NS3 serine protease inhibition by dipeptidyl aldehyde: a QM/MM study.
    Nutho B; Mulholland AJ; Rungrotmongkol T
    Phys Chem Chem Phys; 2019 Jul; 21(27):14945-14956. PubMed ID: 31236554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
    Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
    J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-active carbazole derivatives as inhibitors of the zika virus protease.
    Rassias G; Zogali V; Swarbrick CMD; Ki Chan KW; Chan SA; Gwee CP; Wang S; Kaplanai E; Canko A; Kiousis D; Lescar J; Luo D; Matsoukas MT; Vasudevan SG
    Eur J Med Chem; 2019 Oct; 180():536-545. PubMed ID: 31344613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor.
    Li Y; Zhang Z; Phoo WW; Loh YR; Li R; Yang HY; Jansson AE; Hill J; Keller TH; Nacro K; Luo D; Kang C
    Structure; 2018 Apr; 26(4):555-564.e3. PubMed ID: 29526431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating the inhibitory mechanism of Zika virus NS2B-NS3 protease with dipeptide inhibitors: Insights from molecular docking and molecular dynamics simulations.
    Ullah S; Ullah F; Rahman W; Ullah A; Haider S; Yueguang C
    PLoS One; 2024; 19(8):e0307902. PubMed ID: 39116118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus.
    Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME
    Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
    Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
    Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structures of Zika virus NS2B-NS3 protease in complex with peptidomimetic inhibitors.
    Phoo WW; Zhang Z; Wirawan M; Chew EJC; Chew ABL; Kouretova J; Steinmetzer T; Luo D
    Antiviral Res; 2018 Dec; 160():17-24. PubMed ID: 30315877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease.
    Nie S; Zhao J; Wu X; Yao Y; Wu F; Lin YL; Li X; Kneubehl AR; Vogt MB; Rico-Hesse R; Song Y
    Eur J Med Chem; 2021 Dec; 225():113767. PubMed ID: 34450494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection.
    Starvaggi J; Previti S; Zappalà M; Ettari R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MD simulations reveal alternate conformations of the oxyanion hole in the Zika virus NS2B/NS3 protease.
    Ren J; Lee H; Kotak A; Johnson ME
    Proteins; 2020 Feb; 88(2):345-354. PubMed ID: 31461176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating into the molecular interactions of flavonoids targeting NS2B-NS3 protease from ZIKA virus through
    Yadav R; Selvaraj C; Aarthy M; Kumar P; Kumar A; Singh SK; Giri R
    J Biomol Struct Dyn; 2021 Jan; 39(1):272-284. PubMed ID: 31920173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
    Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
    Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH and non-covalent ligand binding modulate Zika virus NS2B/NS3 protease binding site residues: Discoveries from MD and constant pH MD simulations.
    Santos LH; Caffarena ER; Ferreira RS
    J Biomol Struct Dyn; 2022; 40(20):10359-10372. PubMed ID: 34180376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.